UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of: ~~November~~December 2018

Commission File Number: 001- 37413

~~Concordia~~ADVANZ ~~International~~PHARMA Corp.

(Translation of registrant’s name into English)

5770 Hurontario Street, Suite 310,

Mississauga, Ontario, L5R 3G5

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

On ~~November~~December 295, 2018, ~~Concordia~~ADVANZ ~~International~~PHARMA Corp. (the “Corporation”) ~~announced~~filed, ~~that~~on ~~shareholders~~the ~~voted~~System infor ~~favour~~Electronic ofDocument aAnalysis ~~special~~and ~~resolution~~Retrieval ~~authorizing~~at ~~the~~www.sedar.com, ~~Corporation~~a toForm ~~amend~~51-102F3 ~~its~~Material ~~articles~~Change Report relating to ~~change~~the Corporation changing its name from Concordia International Corp. to ADVANZ PHARMA Corp. ~~In conjunction with this announcement the Corporation is filing the following exhibit:~~

~~Exhibit~~In ~~99.1 Press~~conjunction ~~release~~with ofthis ~~Concordia~~report ~~International~~the ~~Corp.,~~Corporation ~~dated~~is ~~November~~filing ~~29,~~the ~~2018.~~following exhibit:

Exhibit 99.1 Material Change Report dated December 5, 2018.

Exhibit 99.2 Articles of Amendment.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

~~Concordia~~ADVANZ ~~International~~PHARMA Corp. By: /s/ Adeel Ahmad Name: Adeel Ahmad Title: Chief Financial Officer

Date: ~~November~~December 296, 2018

EXHIBIT INDEX

Exhibit No.		Description
99.1		~~Press~~Material ~~release~~Change ofReport ~~Concordia International Corp.,~~ dated ~~November~~December 295, 2018.
99.2		Articles of Amendment.

Filing Compare · ADVANZ PHARMA Corp.